InvestorsHub Logo
Followers 2
Posts 696
Boards Moderated 0
Alias Born 01/13/2001

Re: loch3 post# 33446

Friday, 09/23/2005 10:25:52 PM

Friday, September 23, 2005 10:25:52 PM

Post# of 82595
Phil, not trying to hitch-hike on your thread, but for some reason I wasn't allowed to post a new message. Anyway, I am a bit disconcerted by an article PR by one of DnaPrints competitors, GNSC, who has made an affiliation similar to what I would have expected Gabriel to have made long ago. I don't know anything about this Phamacuetical Company being talked about, but the future testing for drug response should be right down our alley and unless we are being lied to about the scientific capabilities of ADMIXMAPtm, we should be making similar affiliations. Anyway, here is the PR.... in part....

NEW HAVEN, Conn. and TOKYO, Sept. 21 /PRNewswire-FirstCall/ -- Genaissance Pharmaceuticals, Inc. (Nasdaq: GNSC - News) today announced that it has entered into a pharmacogenomic research collaboration with Otsuka Pharmaceutical Co., Ltd. Under the terms of the agreement, Genaissance will apply its HAP(TM) Technology with the goal of identifying genetic markers related to drug response. Genaissance and Otsuka will be co-owners of the intellectual property that results from the collaboration and both companies will be eligible to receive royalties on revenues generated from diagnostic products resulting from the collaboration.

Peace, Blessings & Boat Drinks, Easy